16238-Prostate Cancer-NA-445

Prostate Cancer

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number:

  • Address

3550 N E Loop 286
Paris, TX 75460
P: (903) 785-0031

Search by practice name, trial titles, indicators and specific disease types.